Is Neubase Therapeutics (NBSE) Stock a Buy For 2021?
Greenlight Capital Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 5.2% in 2020, underperforming its benchmark, the S&P 500 Index...